MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer

The treatment of high-risk prostate cancer (HRPCa) is a tremendous challenge for uro-oncologists. The identification of predictive moleculobiological markers allowing risk assessment of lymph node metastasis and systemic progression is essential in establishing effective treatment. In the current st...

Full description

Bibliographic Details
Main Authors: Burkhard Kneitz, Hubertus Riedmiller, Claus-Jürgen Scholz, Susanne Kneitz, Maximilian Burger, Evelyne Lerut, Steven Joniau, Martin Spahn, Markus Krebs, Charis Kalogirou
Format: Article
Language:English
Published: MDPI AG 2013-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/14/11/21414